内镜逆行胰胆管造影术应用于胆总管结石合并尿毒症患者的临床分析

Clinical analysis of endoscopic retrograde cholangiopancreatography in treatment of uremia patients with common bile duct stones

摘要:

目的 评价内镜逆行胰胆管造影术（ERCP）应用于胆总管结石合并尿毒症患者的有效性及安全性。方法 回顾性分析2015年6月－2020年12月17例在苏北人民医院行ERCP治疗的胆总管结石合并尿毒症患者的病例特点、治疗效果及并发症发生情况。结果 17例患者共行19次ERCP，平均1.1次/例，治疗成功率为94.1%（16/17）。术后总体并发症发生率为29.4%（5/17），其中胰腺炎2例（11.8%）、迟发性出血1例（5.9%）和胆道感染2例（11.8%），均经治疗后康复。结论 胆总管结石合并尿毒症患者行ERCP是安全、有效的，但需做好术后并发症的防治措施，以进一步提高ERCP诊治的安全性。

Abstract:

Objective To evaluate the efficacy and safety of endoscopic retrograde cholangiopancreatography (ERCP) in treatment of choledocholithiasis in patients with uremia.Methods Retrospective analysis was performed on the characteristics, therapeutic effects and complications of 17 patients with choledocholithiasis complicated with uremia who received ERCP treatment from June 2015 to December 2020.Results ERCP was performed 19 times in 17 patients with an average of 1.1 times per patient. The success rate of ERCP was 94.1% (16/17). The total postoperative complication incidence was 29.4% (5/17), including 11.8% (2/17) post-ERCP pancreatitis, 5.9% (1/17) delayed bleeding and 11.8% (2/17) biliary tract infection. All the patients recovered after treatment.Conclusion ERCP is safe and effective for choledocholithiasis in uremia patients. However, we should pay attention to the prevention and treatment of postoperative complications in order to further improve the safety of ERCP.